Recently published White Paper reveals ways clinical laboratories and pathology groups can take advantage of growing opportunities in the area of pharmacogenomics

Increased understanding of the genetic basis of an individual’s response to drugs, including how and how quickly a drug is metabolized (pharmacodynamics and pharmacokinetics), has created rich opportunities for the establishment and expansion of PgX services. Expertise such as this that is beyond traditional lab medicine is crucial to the future success of your laboratory. Pharmacodynamics and pharmacokinetics have opened the door to a progressively personalized approach to drug prescription....

Recently published White Paper discusses the importance of clinical diagnostics laboratories having a capable system to handle molecular testing needs

The laboratory industry’s forward thinkers define molecular diagnostics and genetic testing as both the future of pathology and the #1 opportunity to add clinical value while earning appropriate reimbursement. Personalized medicine and predictive medicine have become a reality. As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. Although...

Revisiting the Clinical Pathology Lab’s Problem of Floaters and Other Contaminates

As automation transforms the manual work processes in the histopathology laboratory, “floaters” may become a thing of the past Any histotechnologist and pathologist familiar with the manual work processes commonly in use in histopathology laboratories knows about “floaters.” These are the pesky artifacts that are a consequence of the common practice of manually processing tissue through the series of H&E linear baths required for the proper staining of these samples prior to analysis by...

Threat to Clinical Pathology Laboratories is Payer Pre-Authorization of Genetic Tests

Health insurers want to control the rapid growth in expensive genetic and molecular assays For many clinical laboratories and pathology groups, genetic tests and molecular diagnostic assays are the fastest-growing part of the test menu. This is true both in the increased volume of specimens for genetic tests and the growing number of such medical laboratory tests that are accepted for clinical use. This is a bright spot for the nation’s clinical pathology laboratories. That’s because many...

Pathology Laboratories Take Steps to Bring Web 2.0 Functions into Digital Pathology

Enriched exchange of digital pathology images and clinical knowledge is the goal Digital scanning and digital pathology systems represent a major transformational force in the field of anatomic pathology. Momentum in favor of wider adoption by pathologists and pathology laboratories continues to build, reinforced, in part, by an interesting new development, which one pathologist calls “Pathology 2.0.” Pathology 2.0 describes how Web 2.0 functions can be integrated with digital imaging and...
;